Physician
Internal Medicine
Dr. Taiga Nishihori, MD
|
|
Give Review
Taiga Nishihori, MD works in the field of Internal Medicine. Taiga Nishihori is a published MD. He published 50 publications, including: 'Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.' He accepts all Medicare patients.
Publications
- Pediatric-inspired therapy compared to alloGrafting for Philadelphia chromosome-negative adult ALL in first complete remission.
- Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
- Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic Cell transplantation: a single institution experie...
- Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.
- Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic Cell transplantation.
- A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin Lymphoma.
- Donor-derived constitutional chromosomal abnormalities after allogeneic hematopoietic Cell transplantation: a single-center experience and a review of the literature.
- Ofatumumab in combination with glucocorticoids for primary therapy of Chronic graft vs. host disease: Phase I trial results.
- An open-label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed Myeloma.
- Myeloablative Intravenous Pharmacokinetically Targeted Busulfan Plus Fludarabine As Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients With Non...
- Vaccine therapy for cytomegalovirus in the setting of allogeneic hematopoietic Cell transplantation.
- Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic Syndrome.
- Non-permissive -DPB1 mismatch among otherwise HLA-matched donor-recipient pairs results in increased overall mortality after myeloablative unrelated allogeneic hematop...
- Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transpla...
- Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation.
- Extracorporeal Photopheresis in Steroid-Refractory Acute or Chronic Graft-versus-Host Disease: Results of a Systematic Review of Prospective Studies.
- Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic Cell transplantation in patients with multiple myeloma.
- Pre-transplant 5-azacitidine in high-risk myelodysplastic Syndrome.
- Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic Cell transplantation for adults with ALL in first remission.
- Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple Myeloma.
- Immunotherapy strategies for multiple Myeloma: the present and the future.
- Sequence of novel agents in multiple Myeloma: An instrumental variable analysis.
- High-dose melphalan produces favorable response in a patient with multiple Myeloma and coexisting essential thrombocythemia with JAK2 mutation.
- Phase II study of CD4+guided pentostatin lymphodepletion and pharmacokinetically-targeted busulfan as conditioning for hematopoietic Cell allografting.
- Monoclonal antibodies in conditioning regimens for hematopoietic Cell transplantation.
- Allogeneic hematopoietic Cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma.
- Therapeutic Advances in the Treatment of Primary Plasma Cell Leukemia: a Focus on Hematopoietic Cell Transplantation.
- Diagnostic and therapeutic advances in blastic plasmacytoid dendritic Cell neoplasm: a focus on hematopoietic Cell transplantation.
- Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic Cell transplantation in patients with newly diagnosed multiple myeloma...
- A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic Cell transplantation.
- Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization.
- Bortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myel...
- Role of reduced intensity conditioning in allogeneic hematopoietic Cell transplantation for patients with multiple myeloma.
- Advances in the autologous and allogeneic transplantation strategies for multiple Myeloma.
- Clinical Outcomes of Patients With Plasma Cell Leukemia in the Era of Novel Therapies and Hematopoietic Stem Cell Transplantation Strategies: A Single-Institution Expe...
- The global severity of Chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-r...
- Sirolimus demonstrates activity in the primary therapy of Acute graft-versus-host disease without systemic glucocorticoids.
- Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic Cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malign...
- Hepatobiliary manifestations of Acute myeloid leukemia.
- ATG prevents severe Acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation.
- Pentostatin as rescue therapy for glucocorticoid-refractory Acute and chronic graft-versus-host disease.
- Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for Acute myelo...
- Allogeneic hematopoietic Cell transplantation for myelofibrosis: a 10-year experience at single institution.
- Dysglycemia following glucocorticoid therapy for Acute graft-versus-host disease adversely affects transplantation outcomes.
- Carpal tunnel Syndrome associated with the use of aromatase inhibitors in breast cancer.
- Incidence and management of colorectal Cancer in liver transplant recipients.
- Severe action tremor related to interferon-alpha 2b therapy for malignant Melanoma.
- Three-dimensional conformal radiotherapy for astrocytic tumors involving the eloquent area in children and young adults.
Schools
Hokkaido University School Of Medicine
Beth Israel Med Center
Yale New Haven Hospital
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
Education
-
Yale-New Haven Hospital -
Mount Sinai Beth Israel -
Hokkaido University Faculty of Medicine
Hospital
-
H. Lee Moffitt Cancer Center and Research Institute
Drug Facts
| NPI NUMBER | 1497963979 | |
| NPPES Provider LastName | NISHIHORI | |
| NPPES Provider FirstName | TAIGA | |
| NPPES Provider ZIPCode | 336129416 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 287.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 6.27 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497963979 |
| Last Name Of The Provider | NISHIHORI |
| First Name Of The Provider | TAIGA |
| View All |
Similar Doctors
|
Dr. Maysa T. Ahmad, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jai H. Cho, MD |
|
Dr. Jose I. Lopez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leah K. Krull, MD |
|
|
Dr. William H. Evans Jr., DO |
|
|
Dr. Alexander I. Reiss, MD |
|
Dr. Jeffrey S. Weber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine Chodkiewicz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jawan C. Ayer-Cole, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory M. Springett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James McCluskey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melvyn S. Tockman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Sukaina Nicophene, FNP-BC |